Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially a…
Three performance levels for injection vials, syringes, ampoules and cartridges Clear and consistent structure for s…
Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved…
XORTX Therapeutics Inc. („XORTX“ oder das „Unternehmen“) (NASDAQ: XRTX | TSX-V: XRTX | Frankfurt: ANUA WKN: A3UNZ), ein…
The term “biotherapies” broadly refers to medicinal products, including biopharmaceuticals, that are produced from biolo…
The constant temperature equipment manufacturer LAUDA is launching a new product on the market to start the new year: th…
Biotechnologie ist ein Bereich, auf den sich Ruanda gerade verstärkt spezialisieren möchte mit dem Ziel, sich zu einem a…
New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic,…
Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved C…
. New agreement to establish global commercial manufacturing capacity for Vaxcyte's PCV candidates, VAX-24 and VAX-31,…